Brainsway Ltd - Asset Resilience Ratio
Brainsway Ltd (BWAY) has an Asset Resilience Ratio of 0.97% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Brainsway Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2025)
This chart shows how Brainsway Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Brainsway Ltd asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Brainsway Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Brainsway Ltd to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.14 Million | 0.97% |
| Total Liquid Assets | $1.14 Million | 0.97% |
Asset Resilience Insights
- Limited Liquidity: Brainsway Ltd maintains only 0.97% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Brainsway Ltd Industry Peers by Asset Resilience Ratio
Compare Brainsway Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Brainsway Ltd (2012–2025)
The table below shows the annual Asset Resilience Ratio data for Brainsway Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.27% | $1.43 Million | $112.92 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $94.32 Million | -- |
| 2023-12-31 | 56.32% | $35.47 Million | $62.97 Million | +55.90pp |
| 2022-12-31 | 0.42% | $271.00K | $64.48 Million | -52.96pp |
| 2021-12-31 | 53.38% | $40.43 Million | $75.73 Million | +52.73pp |
| 2020-12-31 | 0.65% | $221.00K | $34.01 Million | +0.08pp |
| 2019-12-31 | 0.57% | $221.00K | $38.74 Million | +0.14pp |
| 2018-12-31 | 0.43% | $101.00K | $23.60 Million | +0.24pp |
| 2017-12-31 | 0.18% | $50.00K | $27.03 Million | -2.75pp |
| 2016-12-31 | 2.93% | $585.00K | $19.96 Million | +0.30pp |
| 2015-12-31 | 2.63% | $585.00K | $22.24 Million | -1.56pp |
| 2014-12-31 | 4.19% | $1.08 Million | $25.77 Million | -3.98pp |
| 2013-12-31 | 8.16% | $1.46 Million | $17.85 Million | -1.74pp |
| 2012-12-31 | 9.91% | $1.06 Million | $10.70 Million | -- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more